ODG
XERS icon

O'Dell Group’s Xeris Biopharma Holdings XERS Stock Holding History

O'Dell Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,316
Closed -$7.79K – 490
2023
Q4 		$7.79K Buy
+3,316
New +$6.12K ﹤0.01% 368
2023
Q3 		– Sell
-3,316
Closed -$8.69K – 498
2023
Q2 		$8.69K Buy
+3,316
New +$8.44K ﹤0.01% 355
2022
Q4 		– Sell
-3,316
Closed -$5K – 414
2022
Q3 		$5K Hold
3,316
– – ﹤0.01% 339
2022
Q2 		$5K Buy
+3,316
New +$7K ﹤0.01% 348
2021
Q4 		– Sell
-584
Closed -$1K – 554
2021
Q3 		$1K Buy
+584
New +$1.7K ﹤0.01% 479

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

O'Dell Group's XERS Position: Q1 2024 in Review

O'Dell Group sold out of Xeris Biopharma Holdings (XERS) in Q1 2024, closing a stake of 3,316 shares — an estimated $7.79K sold.

O'Dell Group first reported a position in XERS in Q3 2021 and held it in 5 quarters. The position peaked at $8.69K in Q2 2023. 143 funds tracked by Wall St. Rank hold XERS as of Q1 2024.

  • O'Dell Group reported no remaining Xeris Biopharma Holdings position as of Q1 2024 after selling out during the quarter.
  • O'Dell Group sold 3,316 Xeris Biopharma Holdings shares in Q1 2024, an estimated $7.79K.
  • O'Dell Group first reported a position in Xeris Biopharma Holdings in Q3 2021 and held it in 5 quarters.
  • O'Dell Group's Xeris Biopharma Holdings position peaked at $8.69K in Q2 2023.
  • 143 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2024.

Based on O'Dell Group's 13F filing for Q1 2024, filed 7 May 2024.